# S9 Nonclinical Evaluation for Anticancer Pharmaceuticals - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/s9-nonclinical-evaluation-for-anticancer-pharmaceuticals/0d1f71ec-dd43-4c57-befe-2d7eb7e145f2

> FDA guidance document: S9 Nonclinical Evaluation for Anticancer Pharmaceuticals. Issue date: March 08, 2010. Get complete insights and analysis.

---

## Details

- Title: S9 Nonclinical Evaluation for Anticancer Pharmaceuticals
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2010-03-08
- Last Changed: 2020-04-30
- Docket Number: <a href="https://www.regulations.gov/docket/ FDA-2009-D-0006"> FDA-2009-D-0006</a>

## Related Documents

- [E2F Development Safety Update Report](https://www.globalkeysolutions.net/guidances/guidance-document/e2f-development-safety-update-report/fce1434f-a2f0-418e-adf4-9803cbc032bd)
- [Q8(R2) Pharmaceutical Development](https://www.globalkeysolutions.net/guidances/guidance-document/q8r2-pharmaceutical-development/952b87d6-d764-4049-94ad-25d668f24c35)
- [E7 Studies in Support of Special Populations; Geriatrics; Questions and Answers](https://www.globalkeysolutions.net/guidances/guidance-document/e7-studies-in-support-of-special-populations-geriatrics-questions-and-answers/763c730c-788a-48d7-a8b1-a2867830bfc9)